Quality of life and memory after vagus nerve stimulator implantation for epilepsy

Canadian Journal of Neurological Sciences

Volumn 35, Issue 3, 2008, Pages 287-296

  McGlone, Jeannette ^a,c   Valdivia, Ivan ^a,d   Penner, Marsha ^b   Williams, Jaime ^c,e   Sadler, R Mark ^a   Clarke, David B ^a  

^a DALHOUSIE UNIVERSITY   (Canada)

^b DALHOUSIE UNIVERSITY   (Canada)

^c QUEEN ELIZABETH II HEALTH SCIENCES CENTRE   (Canada)

^d UNIVERSITY OF OTTAWA   (Canada)

^e UNIVERSITY OF SASKATCHEWAN   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT;

ADULT; ARTICLE; CASE CONTROL STUDY; CLINICAL ARTICLE; CONTROLLED STUDY; DEPRESSION; EPILEPSY; FEMALE; GERIATRIC DEPRESSION SCALE; HUMAN; IMPLANTATION; MALE; MEASUREMENT ERROR; MEMORY DISORDER; PATIENT ASSESSMENT; POSTOPERATIVE PERIOD; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUALITY OF LIFE; QUESTIONNAIRE; RELIABILITY; VAGUS NERVE STIMULATION; VERBAL MEMORY; WECHSLER MEMORY SCALE;

EID: 51349163020     PISSN: 03171671     EISSN: None     Source Type: Journal    
DOI: 10.1017/S0317167100008854     Document Type: Article

References (55)

1. George M, Sackeim H, Rush A, Marangell L, Nahas Z, Husain M, et al. Vagus nerve stimulation: a new tool for brain research and therapy. Biol Psychiatry. 2000; 47: 287-95.
2. Ben-Menachem E, Manon-Espaillat R, Ristanovic R, Wilder B, Stefan H, Mirza W, et al. Vagus nerve stimulation for treatment of partial seizures: 1. a controlled study of effect on seizures. Epilepsia. 1994; 35: 616-26.
3. Handforth A, DeGiorgio C, Schachter S, Uthman B, Naritoku D, Tecoma E, et al. Vagus nerve stimulation therapy for partial-onset seizures. A randomized active-control trial. Neurology. 1998; 51: 48-55.
4. Vonck K, Boon P, D'Have M, Vandekerckhove T, O'Connor S, De Reuck J. Long-term results of vagus nerve stimulation in refractory epilepsy. Seizure. 1999; 8: 328-34.
5. Morris G, Mueller W. The Vagus Nerve Stimulation Group. Long-term treatment with vagus nerve stimulation in patients with refractory epilepsy. Neurology. 1999; 53: 1731-5.
6. Amar AP, Apuzzo ML, Liu CY. Vagus nerve stimulation therapy after failed crania] surgery for intractable epilepsy: results from the vagus nerve stimulation therapy patient outcome registry. Neurosurgery. 2004; 55: 1086-93.
7. Renfroe JB, Wheless JW. Earlier use of adjunctive vagus nerve stimulation therapy for refractory epilepsy. Neurology. 2002; 24 Suppl 4: S26-30.
8. The Vagus Nerve Stimulation Study Group. A randomized controlled trial of chronic vagus nerve stimulation for treatment of medically intractable seizures. Neurology. 1995; 45: 224-30.
9. Chadwick D. Vagal-nerve stimulation for epilepsy. Lancet. 2001; 357: 1726-7.
10. Baker GA, Gagnon D, McNulty P. The relationship between seizure frequency, seizure type and quality of life: findings from three European countries. Epilepsy Res. 1998; 30: 231-40.
11. Devinsky O. Quality of life in epilepsy. Time to practice what we preach. Epilepsy Behav. 2000; 1: 89-90.
12. Sirven J, Sperling M, Naritoku D, Schachter S, Labar D, Holmes M, et al. Vagus nerve stimulation therapy for epilepsy in older adults. Neurology. 2000; 54: 1179-82.
13. Cramer J. Exploration of changes in health-related quality of life after three months of vagus nerve stimulation. Epilepsy Behav. 2001; 2: 460-5.
14. Ergene E, Behr P, Shih J. Quality-of-life assessment in patients treated with vagus nerve stimulation. Epilepsy Behav. 2001; 2: 284-7.
15. McLachlan R, Sadler M, Pillay N, Guberman A, Jones M, Wiebe S, et al. Quality of life after vagus nerve stimulation for intractable epilepsy: Is seizure control the only contributing factor? Eur Neurol. 2003; 50: 16-19.
16. Morrow JI, Bingham E, Craig JJ, Grey, WJ. Vagus nerve stimulation in patients with refractory epilepsy. Effect on seizure frequency, severity and quality of life. Seizure. 2000; 9: 442-5.
17. Chavel SM, Westerveld M, Spencer S. Long-term outcome of vagus nerve stimulation for refractory partial epilepsy. Epilepsy Behav. 2003; 4: 302-9.
18. Gill T, Feinstein A. A critical appraisal of the quality of quality-of-life measurements. JAMA. 1994; 272: 619-26.
19. Hoppe C, Helmstaedter C, Scherrmann J, Elger CE. Self-reported mood changes following 6 months of vagus nerve stimulation in epilepsy patient. Epilepsy Behav. 2001a; 4: 335-42.
20. Dodrill C, Morris G. Effects of vagal nerve stimulation on cognition and quality of life in epilepsy. Epilepsy Behav. 2001; 2: 46-53.
21. Baker G, Jacoby A. Quality of life in epilepsy. Amsterdam: Harwood Academic Publishers; 2000.
22. Wiebe S, Matijevic S, Eliasziw M, Derry P. Clinically important change in quality of life in epilepsy. J Neurol Neurosurg Psychiatry. 2002; 73: 116-20.
23. Fisher R, Handforth A. Reassessment: Vagus nerve stimulation for epilepsy: A report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology. 1999; 53: 666-9.
24. Clark K, Naritoku D, Smith D, Browning R, Jensen R. Enhanced recognition memory following vagus nerve stimulation in human subjects. Nat Neurosci. 1999; 2: 94-8.
25. Ghacibeh GA, Shenker JI, Shenal B, Uthman BM, Heilman KM. The influence of vagus nerve stimulation on memory. Cog Behav Neurol. 2006; 19: 199-22.
26. Helmstaedter C, Hoppe C, Elger C. Memory alterations during acute high-intensity vagus nerve stimulation. Epilepsy Res. 2001; 47: 37-42.
27. Hoppe C, Helmstaedter C, Scherrmann J, Elger CE. No evidence for cognitive side effects after six months of vagus nerve stimulation in epilepsy patients. Epilepsy Behav. 2001b; 2: 351-6.
28. Clarke B, Upton A, Griffin H. Cognitive motor function after electrical stimulation of the vagus nerve. Pacing Clin Electrophysiol. 1992; 15: 1603-7.
29. Sackeim H, Keilp J, Rush A, George M, Marangell L, Dormer J, et al. The effects of vagus nerve stimulation on cognitive performance in patients with treatment-resistant depression. Neuropsychiatry Neuropsychol Behav Neurol. 2001; 14: 53-62.
30. Small S. Age related memory decline. Arch Neurol. 2001; 58: 360-4.
31. Jacobson N, Truax P. Clinical significance: A statistical approach to defining meaningful change in psychotherapy research. J Consult Clin Psychol. 1991; 59: 12-19.
32. Wiebe S, Blume W, Girvin J, Eliasziw M. A randomized, controlled trial of surgery for temporal-lobe epilepsy. N Eng J Med. 2001; 345: 311-8.
33. Wilkinson G. WRAT 3 Administration Manual. Wide Range, Wilmington; 1993.
34. Devinsky O, Vickrey BG, Cramer J, Perrine K, Hermann B, Meador K, et al. Development of the Quality of Life in Epilepsy Inventory. Epilepsia. 1995; 36: 1089-104.
35. Harden C, Pulver M, Ravdin L, Nikolov B, Halper J, Labar D. A pilot study of mood in epilepsy patients treated with vagus nerve stimulation. Epilepsy Behav. 2000; 1: 93-9.
36. Yesavage J, Brink T, Rose T, Adey M. The geriatric depression scale: Comparison with other self-report and psychiatric scales. In: Crook J, Ferris S, Bartus R, editors. Assessment in geriatric psychopharmacology. Mark Prowley Associates, Connecticut; 1986. p. 153-67.
37. Montorio I, Izal M. The Geriatric Depression Scale: A review of its development and utility. Int Psychogeriatr. 1996; 8: 103-12.
38. Humphrey D, McGlone J, Leffley A, Gupta S, Evans D. Manual for the Memory Observation Questionnaire and Memory Observation Questionnaire - 2. King's College, London, Ontario; 1992.
39. Wechsler D. WMS-III Administration and Scoring Manual. The Psychological Corporation, San Antonio; 1997.
40. McGlone J, Wands K. Self-report of memory function in patients with temporal lobe epilepsy and temporal lobectomy. Cortex. 1991; 27: 19-28.
41. McGlone J. Memory complaints before and after temporal lobectomy: Do they predict memory performance or lesion laterality? Epilepsia. 1994; 35: 529-39.
42. Fisher S, Greenberg RP. The limits of biological treatments for psychological distress: Comparisons with psychotherapy and placebo. Lawrence Erlbaum Associates, New Jersey; 1989.
43. Kirsch I. Conditioning, expectancy, and the placebo effect: A comment on Stewart-Williams and Podd. Psychol Bull. 2004; 130: 341-3.
44. Kirsch I, Sapirstein G. Listening to Prozac but hearing placebo: A meta-analysis of antidepressant medication. Prevention & Treatment. 1998; 1, published online: http://journals.apa.org/prevention/volume1/ pre0010002a.html.
45. Ergene E, Behr PK, Shih JJ. Quality-of-life assessment in patients treated with vagus nerve stimulation. Epilepsy Behav. 2001; 2: 284-7.
46. Labar D. Effects of vagal nerve stimulation on cognition and quality of life. Epilepsy Behav. 2001; 2: 161-2.
47. Baker G, Camfield C, Camfield P, Cramer J, Elger C, Johnson A, et al. ILAE Commission Report Commission on outcome measurement in Epilepsy, 1994-1997: Final Report. Epilepsia. 1998; 39: 213-31.
48. Kellett M, Smith D, Baker G, Chadwick D. Quality of life after epilepsy. J Neurol Neurosurg Psychiatry. 1997; 63: 52-8.
49. Leidy N, Elixhauser A, Vickrey B, Means E, Willian M. Seizure frequency and the health-related quality of life of adults with epilepsy. Neurology. 1999; 53: 162-6.
50. Baker G, Jacoby A, Buck D, Stalgis C, Monnet D. Quality of life of people with epilepsy: a European study. Epilepsia. 1997; 38: 353-62.
51. von Steinbuchel N, Heel S, Bullinger M. Review of health-related measures of quality of life pertaining to epilepsy which are currently. In Baker G, Jacoby A, editors. sQuality of Life in epilepsy: beyond seizure counts in assessment and treatment. London: Harwood Press; 2000. p. 65-102.
52. Wilkins D. Reassessment: vagus nerve stimulation for Epilepsy. Neurology. 2000; 54: 2027.
53. Boon P, D'Have M, Van Walleghem P, Michielsen G, Vonck K, Caemaert J, et al. Direct medical costs of refractory epilepsy incurred by three different treatment modalities: a prospective assessment. Epilepsia. 2002; 43: 96-102.
54. Harden CL, Pulver MC, Ravdin LD, Nikolov, B, Halper JP, Labar DR. A pilot study of mood in epilepsy patients treated with vagus nerve stimulation. Epilepsy Behav. 2000; 1: 93-9.
55. Krapohl BD, Deutlinger M, Kömürcü F. Vagus nerve stimulation: treatment modality for epilepsy. Medsurg Nurs. 2007; 16: 39-44.